Small-cap stock under ₹50 to be in focus on Monday. Details here
Sudarshan Pharma's share capital increased to ₹24.96 crore after allotting 90 lakh equity shares from warrant conversions. Promoter shareholding rose to 58.93%, while non-promoters hold 41.07%. The allotment enhances capital base and share value.
Small-cap stock under ₹50: Small-cap stock under ₹50 Sudarshan Pharma Industries share price will be in focus on Monday after it allotted 90 lakh equity shares on warrant conversion.
The small-cap stock has been in the green in recent times. It has risen 22% in 1 month, 40% in 3 months and 48% in 6 months. However, in the last 1 year, it has just added 17%.
The scrip has hit its 52-week high of ₹36.95 in May 2026 and its 52-week low of ₹18.50 in January 2026.
Sudarshan Pharma Industries Ltd has approved the allotment of 90 lakh equity shares following the conversion of warrants issued on a preferential basis to promoter group members.
The company's Warrants Committee, at its meeting held on June 12, 2026, approved the conversion of 9 lakh warrants into 90 lakh fully paid-up equity shares, resulting in an infusion of ₹11.46 crore through the receipt of the balance subscription amount from the warrant holders. The allotment is expected to strengthen the company's capital base while increasing promoter shareholding in the company.
Promoters convert warrants into 90 lakh shares
The company said the equity shares were allotted at an issue price of ₹16.983 per share, including a premium of ₹15.983 per share, pursuant to the conversion of warrants originally issued at ₹169.83 each. The conversion was undertaken by promoters Hemal Vasantrai Mehta and Sachin Vasantrai Mehta, who converted 4.5 lakh warrants each and were allotted 45 lakh equity shares apiece. The promoters paid the balance amount of ₹127.37 per warrant, representing 75% of the warrant issue price, aggregating to ₹11.46 crore.
In its regulatory filing, the company said, “The newly allotted equity shares shall rank pari-passu in all respects with the existing equity shares of the Company.”
Following the allotment, Sudarshan Pharma's issued and paid-up share capital increased to ₹24.96 crore, comprising 24.96 crore equity shares of Re 1 each. The company stated that promoter and promoter group shareholding now stands at 58.93%, while non-promoter shareholding is 41.07%.
Sudarshan Pharma added that the original warrant terms allowed holders to exercise their conversion rights within 18 months from the date of allotment, with 25% of the issue price paid upfront at the time of subscription and the remaining 75% payable upon conversion.
Disclaimer: This story is for educational purposes only. Please consult with an investment advisor before making any investment decisions.
About the Author
Pranati Deva is a seasoned financial journalist with over a decade of experience in high-pressure newsroom environments, currently working as a Senior Sub Editor at LiveMint. Over the years, she has developed a reputation for sharp editorial judgement, a strong grasp of market dynamics, and the ability to translate complex financial developments into clear, engaging stories for a wide audience. <br><br> Her core areas of coverage include stock markets, leading listed companies, currencies, and commodities, with a particular strength in fast-paced, real-time market reporting. She is known for handling breaking market news, earnings-driven stock movements, and macroeconomic developments with speed, accuracy, and context—qualities that are essential in financial journalism. <br><br> Pranati has built a diverse and credible professional track record across some of India’s most respected news organisations, including MintGenie, CNBC-TV18, Business Standard and EconomicTimes.com. During her stints at these platforms, she produced data-driven market stories, curated and steered live blogs during volatile trading sessions, and conducted interviews with market veterans, fund managers, economists, and industry experts. Her work often combines on-ground reporting with analytical depth, helping readers make sense of daily market fluctuations and longer-term trends. An alumnus of the Symbiosis Institute of Media and Communications and Hansraj College, University of Delhi, Pranati brings a strong academic foundation to her journalism. She specialises in real-time financial reporting, with a keen focus on precision, balance, and insight, aiming to decode market movements in a way that is both informative and accessible to readers across experience levels.
Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.